Edwards Lifesciences exec sells 1,240 shares

Edwards Lifesciences Corp (EW) reported an insider sale by Wayne Markowitz, CVP, JAPAC.

Rhea-AI Filing Summary

Edwards Lifesciences Corp (EW) reported an insider sale by Wayne Markowitz, CVP, JAPAC. On 2026-08-26, he sold 1,240 shares of Common Stock in a sale classified as an open market or private transaction at a reported price of $91.465 per share. After this transaction, he directly holds 20,293.5581 shares of Edwards Lifesciences common stock. The filing notes that it reflects only changes in beneficial ownership and does not list all securities beneficially owned.

Insider Trade Summary

Net Seller: 1,240 shares

Net Sell 1 txn

Insider Markowitz Wayne

Role CVP, JAPAC

Sold 1,240 shs ($113K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,240	$91.465	$113K

Holdings After Transaction: Common Stock — 20,293.5581 shares (Direct)

Key Figures

Shares sold: 1,240 shares Sale price per share: $91.465 per share Shares owned after transaction: 20,293.5581 shares +2 more

5 metrics

Shares sold 1,240 shares Common Stock sale on 2026-08-26 by Wayne Markowitz

Sale price per share $91.465 per share Reported price for the 1,240-share Common Stock sale

Shares owned after transaction 20,293.5581 shares Direct Common Stock holdings of Wayne Markowitz following the sale

Net buy/sell shares -1,240 shares Net effect of reported transactions in this Form 4

Number of sell transactions 1 transaction SellCount in transaction summary

Key Terms

beneficial ownership, Common Stock, Reporting Person

3 terms

beneficial ownership financial

"This Form 4 reflects changes in beneficial ownership only"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Common Stock financial

"security_title: Common Stock in the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Reporting Person regulatory

"does not identify other securities of the Issuer beneficially owned by the Reporting Person"

FAQ

What insider transaction did EW disclose for Wayne Markowitz?

Edwards Lifesciences disclosed that Wayne Markowitz, CVP, JAPAC, sold 1,240 shares of Common Stock on 2026-08-26 in a transaction classified as a sale in the open market or a private transaction at $91.465 per share.

How many EW shares does Wayne Markowitz hold after this Form 4 transaction?

After the reported sale, Wayne Markowitz directly holds 20,293.5581 shares of Edwards Lifesciences Corp Common Stock, as stated in the Form 4 filing.

What was the price per share in Wayne Markowitz’s EW stock sale?

The Form 4 reports that Wayne Markowitz’s sale of Edwards Lifesciences Corp Common Stock on 2026-08-26 was executed at $91.465 per share.

Does this EW Form 4 show all securities owned by Wayne Markowitz?

No. The Form 4 states that it reflects changes in beneficial ownership only and does not identify other securities of Edwards Lifesciences Corp beneficially owned by Wayne Markowitz.

Was the EW insider sale under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not affirmed (set to false), and no footnote indicates a trading plan, so the sale is not identified as made under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 06:01 PM Accepted by SEC EDGAR 08/26/2026 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Markowitz Wayne

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP, JAPAC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2026		S		1,240	D	$91.465	20,293.5581	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)